Nasonex (Mometasone Furoate)

Mometasone furoate is a potent glucocorticoid that binds to intracellular glucocorticoid receptors in nasal tissue. This binding alters gene expression, suppressing inflammatory cytokines and mediators, which decreases swelling, mucus production, and vascular leakage in the nasal passages.

The prescribed dose of Nasonex is determined by the treating clinician based on the patient’s age, severity of symptoms, and specific indication. The prescriber will provide individualized instructions on the number of sprays per nostril and the frequency of administration.

Safety data for Nasonex in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare professional before initiating therapy.

To request Nasonex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasonex (mometasone furoate) is a high‑potency intranasal corticosteroid with a favorable safety profile when used as directed. Compared with lower‑potency options such as fluticasone, mometasone may achieve comparable symptom control at similar or lower dosing frequencies, but choice of therapy should be individualized by the prescriber.

Nasonex should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and do not freeze the product.

Nasonex is a metered‑dose nasal spray. The user gently blows the nose, inserts the tip into one nostril, closes the opposite nostril, and sprays the prescribed number of actuations while breathing in gently. The process is repeated for the other nostril as directed by the prescriber.

Serious adverse events, though rare, include nasal septal perforation, severe allergic reactions such as anaphylaxis, and systemic effects like adrenal suppression when used at high doses for prolonged periods. Patients should seek immediate medical attention if they experience unusual bleeding, severe headache, or signs of an allergic reaction.

Nasonex is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with active untreated fungal, bacterial, or viral infections of the nasal passages unless directed by a physician.